[Federal Register Volume 86, Number 2 (Tuesday, January 5, 2021)]
[Notices]
[Page 317]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-29120]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group; Pathophysiological Basis of Mental 
Disorders and Addictions Study Section.
    Date: February 3-4, 2021.
    Time: 9:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Boris P. Sokolov, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5217A, MSC 7846, Bethesda, MD 
20892, 301-408-9115, [email protected].

    Name of Committee: Biological Chemistry and Macromolecular 
Biophysics Integrated Review Group; Synthetic and Biological 
Chemistry A Study Section.
    Date: February 3-4, 2021.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Anita Szajek, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4187, Bethesda, MD 20892, 301-827-6276, 
[email protected].

    Name of Committee: Cell Biology Integrated Review Group; 
Membrane Biology and Protein Processing Study Section.
    Date: February 3-4, 2021.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Kevin Czaplinski, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-435-0000, 
[email protected].

    Name of Committee: Healthcare Delivery and Methodologies 
Integrated Review Group; Community Influences on Health Behavior 
Study Section.
    Date: February 3-4, 2021.
    Time: 10:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Tasmeen Weik, DRPH, MPH, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3141, Bethesda, MD 20892, 301-
827-6480, [email protected].

    Name of Committee: Molecular, Cellular and Developmental 
Neuroscience Integrated Review Group; Neurogenesis and Cell Fate 
Study Section.
    Date: February 3-4, 2021.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Joanne T. Fujii, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4184, MSC 7850, Bethesda, MD 
20892, (301) 435-1178, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: December 29, 2020.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-29120 Filed 1-4-21; 8:45 am]
BILLING CODE 4140-01-P